Literature DB >> 11410146

Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.

D Wodarz1, S E Hall, K Usuku, M Osame, G S Ogg, A J McMichael, M A Nowak, C R Bangham.   

Abstract

The correlation between virus load and specific cytotoxic T-lymphocyte (CTL) frequency during the chronic phase in human immunodeficiency virus type 1 (HIV-1) infection has been found to be negative in cross-sectional studies. We report here that, in infection with the related retrovirus human T-cell leukaemia virus type 1 (HTLV-1), the correlation is positive in asymptomatic carriers and zero in patients with the associated inflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). We demonstrate that the direction of the correlation may depend on the efficacy of the CTL response using mathematical models. We conclude that the CTL response is effective in asymptomatic carriers of HTLV-1, but ineffective in patients with HAM/TSP. Virus-mediated impairment of specific CTL production in HIV-1 infection can account for the negative correlation observed.

Entities:  

Mesh:

Year:  2001        PMID: 11410146      PMCID: PMC1088729          DOI: 10.1098/rspb.2001.1608

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  21 in total

1.  Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.

Authors:  Gabrielle T Belz; Dominik Wodarz; Gabriela Diaz; Martin A Nowak; Peter C Doherty
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

3.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Authors:  Iris Castro; Teresa M Giret; Diogo M Magnani; Helen S Maxwell; Oliver Umland; Jessica K Perry; Jerilyn K Pecotte; Kathleen M Brasky; Glen N Barber; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

5.  Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response.

Authors:  Atsuhiko Hasegawa; Takashi Ohashi; Shino Hanabuchi; Hirotomo Kato; Fumiyo Takemura; Takao Masuda; Mari Kannagi
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 6.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  The role of the cytotoxic T-lymphocyte response and virus cytopathogenicity in the virus decline during antiviral therapy.

Authors:  Vitaly V Ganusov
Journal:  Proc Biol Sci       Date:  2003-07-22       Impact factor: 5.349

9.  Immune responses and the emergence of drug-resistant virus strains in vivo.

Authors:  Dominik Wodarz; Alun L Lloyd
Journal:  Proc Biol Sci       Date:  2004-06-07       Impact factor: 5.349

10.  How does HTLV-I persist despite a strong cell-mediated immune response?

Authors:  Becca Asquith; Charles R M Bangham
Journal:  Trends Immunol       Date:  2007-11-26       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.